Mufson Howe Hunter, a leading investment banking firm serving middle market companies, is pleased to announce the acquisition of Agilis Med Holdings, LLC by AdaptHealth LLC (NasdaqCM: AHCO), a principal provider of home healthcare equipment and medical supplies.
Agilis Med Holdings, LLC is a diversified and innovative healthcare e-commerce retailer specializing in the treatment of sleep apnea and various respiratory conditions.
AdaptHealth LLC (NasdaqCM: AHCO) provides a full suite of medical products and solutions designed to help customers manage chronic conditions in the home. AdaptHealth, one of the largest US suppliers of DME, services approximately 1.8 million patients annually in all 50 states through its extensive national network (i.e., 269 locations in 41 states).
Mufson Howe Hunter acted as the exclusive financial advisor to Agilis Med Holdings, LLC. Stradley Ronon served as exclusive legal advisor to Agilis Medical Holdings, LLC.
Tony Zadnik, CEO of Agilis Med Holdings, LLC stated, “Working with Mufson Howe Hunter was an obvious choice which proved to be invaluable at every turn. From the onset, Isabel, Jonathan and Mike immersed themselves in the business, assisted with focusing our message, supported us through ongoing negotiations and, ultimately, helped structure a multi-phased, win-win process. Without their methodical approach, oversight and consummate partnership, it would have been difficult to achieve an outcome that met my expectations.”
Mufson Howe Hunter & Co. LLC, an investment banking firm established in 2004, focuses on merger and acquisition transactions as well as the placement of growth capital for middle market companies. MHH’s senior investment bankers each has over two decades of transactional experience across the following sectors: business services, consumer, industrials and technology services. MHH advises both public and privately-held companies, with a particular focus on family-held and privately-owned businesses.
